Sudden or cardiac deaths on ibrutinib based therapy were associated with a prior history of hypertension or cardiac disease and the use of ace-inhibitors at study entry: analysis from the Phase III NCRI FLAIR Trial
Munir, T. Pitchford, A. Bloor, Adrian Broom, A. Young, M. Ben, K. Walewska, R. Furtado, M. Preston, G. Neilson, J. R.
Munir, T.
Pitchford, A.
Bloor, Adrian
Broom, A.
Young, M.
Ben, K.
Walewska, R.
Furtado, M.
Preston, G.
Neilson, J. R.
Citations
Altmetric:
Abstract
Authors
Munir, T.
Pitchford, A.
Bloor, Adrian
Broom, A.
Young, M.
Ben, K.
Walewska, R.
Furtado, M.
Preston, G.
Neilson, J. R.
Pemberton, N.
Sidra, G.
Morley, N.
Cwynarski, K.
Schuh, A.
Forconi, F.
Gatto, S.
Paneesha, S.
Fox, C. P.
Howard, D.
Hockaday, A.
Cairns, D.
Jackson, S.
Greatorex, N.
Patten, P. E.
Allsup, D.
Hillmen, P.
Pitchford, A.
Bloor, Adrian
Broom, A.
Young, M.
Ben, K.
Walewska, R.
Furtado, M.
Preston, G.
Neilson, J. R.
Pemberton, N.
Sidra, G.
Morley, N.
Cwynarski, K.
Schuh, A.
Forconi, F.
Gatto, S.
Paneesha, S.
Fox, C. P.
Howard, D.
Hockaday, A.
Cairns, D.
Jackson, S.
Greatorex, N.
Patten, P. E.
Allsup, D.
Hillmen, P.
Description
Date
2021
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Munir T, Pitchford A, Bloor A, Broom A, Young M, Ben K, et al. Sudden or Cardiac Deaths on IbrutinibBased Therapy Were Associated with a Prior History of Hypertension or Cardiac Disease and the Use of ACE-Inhibitors at Study Entry: Analysis from the Phase III NCRI FLAIR Trial. Blood. 2021 Nov;138. PubMed PMID: WOS:000736413902149.